nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0644	0.277	CbGbCtD
Gemcitabine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0574	0.247	CbGbCtD
Gemcitabine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0415	0.178	CbGbCtD
Gemcitabine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0285	0.123	CbGbCtD
Gemcitabine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0213	0.0914	CbGbCtD
Gemcitabine—ABCB1—Losartan—type 2 diabetes mellitus	0.0194	0.0836	CbGbCtD
Gemcitabine—SLC28A1—nephron tubule—type 2 diabetes mellitus	0.00575	0.0411	CbGeAlD
Gemcitabine—SLC28A1—kidney—type 2 diabetes mellitus	0.00505	0.0362	CbGeAlD
Gemcitabine—SLC28A1—cortex of kidney—type 2 diabetes mellitus	0.00492	0.0352	CbGeAlD
Gemcitabine—SLC28A3—islet of Langerhans—type 2 diabetes mellitus	0.00436	0.0312	CbGeAlD
Gemcitabine—CMPK1—islet of Langerhans—type 2 diabetes mellitus	0.00379	0.0272	CbGeAlD
Gemcitabine—POLD1—pancreas—type 2 diabetes mellitus	0.00334	0.0239	CbGeAlD
Gemcitabine—Azacitidine—DNMT1—type 2 diabetes mellitus	0.00331	0.401	CrCbGaD
Gemcitabine—Decitabine—DNMT1—type 2 diabetes mellitus	0.00323	0.392	CrCbGaD
Gemcitabine—SLC28A1—liver—type 2 diabetes mellitus	0.00319	0.0229	CbGeAlD
Gemcitabine—SLC28A3—pancreas—type 2 diabetes mellitus	0.00306	0.0219	CbGeAlD
Gemcitabine—CMPK1—nephron tubule—type 2 diabetes mellitus	0.00305	0.0219	CbGeAlD
Gemcitabine—POLD1—adipose tissue—type 2 diabetes mellitus	0.00303	0.0217	CbGeAlD
Gemcitabine—SLC29A2—cardiovascular system—type 2 diabetes mellitus	0.00288	0.0206	CbGeAlD
Gemcitabine—SLC28A3—adipose tissue—type 2 diabetes mellitus	0.00278	0.0199	CbGeAlD
Gemcitabine—CMPK1—cardiovascular system—type 2 diabetes mellitus	0.00274	0.0196	CbGeAlD
Gemcitabine—CDA—adipose tissue—type 2 diabetes mellitus	0.00272	0.0195	CbGeAlD
Gemcitabine—CMPK1—kidney—type 2 diabetes mellitus	0.00268	0.0192	CbGeAlD
Gemcitabine—CMPK1—pancreas—type 2 diabetes mellitus	0.00267	0.0191	CbGeAlD
Gemcitabine—POLA1—retina—type 2 diabetes mellitus	0.00262	0.0188	CbGeAlD
Gemcitabine—CMPK1—cortex of kidney—type 2 diabetes mellitus	0.00261	0.0187	CbGeAlD
Gemcitabine—SLC29A2—adipose tissue—type 2 diabetes mellitus	0.00254	0.0182	CbGeAlD
Gemcitabine—POLE—cortex of kidney—type 2 diabetes mellitus	0.00245	0.0175	CbGeAlD
Gemcitabine—RRM1—islet of Langerhans—type 2 diabetes mellitus	0.00243	0.0174	CbGeAlD
Gemcitabine—CMPK1—adipose tissue—type 2 diabetes mellitus	0.00242	0.0173	CbGeAlD
Gemcitabine—POLE—adipose tissue—type 2 diabetes mellitus	0.00227	0.0162	CbGeAlD
Gemcitabine—POLD1—liver—type 2 diabetes mellitus	0.00213	0.0152	CbGeAlD
Gemcitabine—RRM2—cardiovascular system—type 2 diabetes mellitus	0.00212	0.0152	CbGeAlD
Gemcitabine—RRM1—retina—type 2 diabetes mellitus	0.00208	0.0149	CbGeAlD
Gemcitabine—RRM2—kidney—type 2 diabetes mellitus	0.00207	0.0148	CbGeAlD
Gemcitabine—SLC29A1—islet of Langerhans—type 2 diabetes mellitus	0.00198	0.0142	CbGeAlD
Gemcitabine—RRM1—nephron tubule—type 2 diabetes mellitus	0.00196	0.014	CbGeAlD
Gemcitabine—POLA1—adipose tissue—type 2 diabetes mellitus	0.00195	0.014	CbGeAlD
Gemcitabine—TYMS—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00193	1	CbGdCrCtD
Gemcitabine—CDA—liver—type 2 diabetes mellitus	0.00191	0.0137	CbGeAlD
Gemcitabine—DCK—islet of Langerhans—type 2 diabetes mellitus	0.00189	0.0135	CbGeAlD
Gemcitabine—RRM2—adipose tissue—type 2 diabetes mellitus	0.00187	0.0134	CbGeAlD
Gemcitabine—SLC29A2—liver—type 2 diabetes mellitus	0.00178	0.0128	CbGeAlD
Gemcitabine—TYMS—nephron tubule—type 2 diabetes mellitus	0.00177	0.0127	CbGeAlD
Gemcitabine—RRM1—cardiovascular system—type 2 diabetes mellitus	0.00176	0.0126	CbGeAlD
Gemcitabine—RRM1—kidney—type 2 diabetes mellitus	0.00172	0.0123	CbGeAlD
Gemcitabine—RRM1—pancreas—type 2 diabetes mellitus	0.00171	0.0122	CbGeAlD
Gemcitabine—CMPK1—liver—type 2 diabetes mellitus	0.0017	0.0121	CbGeAlD
Gemcitabine—RRM1—cortex of kidney—type 2 diabetes mellitus	0.00168	0.012	CbGeAlD
Gemcitabine—DCK—retina—type 2 diabetes mellitus	0.00161	0.0116	CbGeAlD
Gemcitabine—POLE—liver—type 2 diabetes mellitus	0.00159	0.0114	CbGeAlD
Gemcitabine—RRM1—adipose tissue—type 2 diabetes mellitus	0.00155	0.0111	CbGeAlD
Gemcitabine—DCK—nephron tubule—type 2 diabetes mellitus	0.00152	0.0109	CbGeAlD
Gemcitabine—TYMS—cortex of kidney—type 2 diabetes mellitus	0.00152	0.0109	CbGeAlD
Gemcitabine—SLC29A1—cardiovascular system—type 2 diabetes mellitus	0.00143	0.0102	CbGeAlD
Gemcitabine—TYMS—adipose tissue—type 2 diabetes mellitus	0.00141	0.0101	CbGeAlD
Gemcitabine—SLC29A1—kidney—type 2 diabetes mellitus	0.0014	0.01	CbGeAlD
Gemcitabine—SLC29A1—pancreas—type 2 diabetes mellitus	0.00139	0.00995	CbGeAlD
Gemcitabine—POLA1—liver—type 2 diabetes mellitus	0.00137	0.00981	CbGeAlD
Gemcitabine—SLC29A1—cortex of kidney—type 2 diabetes mellitus	0.00136	0.00975	CbGeAlD
Gemcitabine—DCK—pancreas—type 2 diabetes mellitus	0.00133	0.0095	CbGeAlD
Gemcitabine—RRM2—liver—type 2 diabetes mellitus	0.00131	0.00937	CbGeAlD
Gemcitabine—DCK—cortex of kidney—type 2 diabetes mellitus	0.0013	0.00932	CbGeAlD
Gemcitabine—ABCC10—kidney—type 2 diabetes mellitus	0.00127	0.00912	CbGeAlD
Gemcitabine—SLC29A1—adipose tissue—type 2 diabetes mellitus	0.00126	0.00903	CbGeAlD
Gemcitabine—ABCC10—cortex of kidney—type 2 diabetes mellitus	0.00124	0.00888	CbGeAlD
Gemcitabine—DCK—adipose tissue—type 2 diabetes mellitus	0.0012	0.00862	CbGeAlD
Gemcitabine—ABCC10—adipose tissue—type 2 diabetes mellitus	0.00115	0.00822	CbGeAlD
Gemcitabine—RRM1—liver—type 2 diabetes mellitus	0.00109	0.00779	CbGeAlD
Gemcitabine—TYMS—liver—type 2 diabetes mellitus	0.000986	0.00706	CbGeAlD
Gemcitabine—Lamivudine—ABCC2—type 2 diabetes mellitus	0.000932	0.113	CrCbGaD
Gemcitabine—SLC29A1—liver—type 2 diabetes mellitus	0.000884	0.00633	CbGeAlD
Gemcitabine—DCK—liver—type 2 diabetes mellitus	0.000845	0.00605	CbGeAlD
Gemcitabine—ABCC10—liver—type 2 diabetes mellitus	0.000805	0.00576	CbGeAlD
Gemcitabine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000519	0.00372	CbGeAlD
Gemcitabine—Zalcitabine—CYP3A4—type 2 diabetes mellitus	0.00046	0.0559	CrCbGaD
Gemcitabine—ABCB1—retina—type 2 diabetes mellitus	0.000444	0.00318	CbGeAlD
Gemcitabine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000418	0.003	CbGeAlD
Gemcitabine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000376	0.00269	CbGeAlD
Gemcitabine—ABCB1—kidney—type 2 diabetes mellitus	0.000368	0.00263	CbGeAlD
Gemcitabine—ABCB1—pancreas—type 2 diabetes mellitus	0.000365	0.00261	CbGeAlD
Gemcitabine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000358	0.00256	CbGeAlD
Gemcitabine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000331	0.00237	CbGeAlD
Gemcitabine—Cytarabine—CYP3A4—type 2 diabetes mellitus	0.000309	0.0375	CrCbGaD
Gemcitabine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000246	0.000639	CcSEcCtD
Gemcitabine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000245	0.000639	CcSEcCtD
Gemcitabine—Oedema—Valsartan—type 2 diabetes mellitus	0.000245	0.000639	CcSEcCtD
Gemcitabine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000245	0.000638	CcSEcCtD
Gemcitabine—Infection—Valsartan—type 2 diabetes mellitus	0.000244	0.000634	CcSEcCtD
Gemcitabine—Rash—Glipizide—type 2 diabetes mellitus	0.000243	0.000634	CcSEcCtD
Gemcitabine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000243	0.000634	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000243	0.000633	CcSEcCtD
Gemcitabine—Erythema—Losartan—type 2 diabetes mellitus	0.000243	0.000633	CcSEcCtD
Gemcitabine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000242	0.000631	CcSEcCtD
Gemcitabine—Oedema—Orlistat—type 2 diabetes mellitus	0.000242	0.000631	CcSEcCtD
Gemcitabine—Headache—Glipizide—type 2 diabetes mellitus	0.000242	0.00063	CcSEcCtD
Gemcitabine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000241	0.000629	CcSEcCtD
Gemcitabine—Infection—Orlistat—type 2 diabetes mellitus	0.000241	0.000627	CcSEcCtD
Gemcitabine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00024	0.000626	CcSEcCtD
Gemcitabine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00024	0.000625	CcSEcCtD
Gemcitabine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00024	0.000624	CcSEcCtD
Gemcitabine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00024	0.000624	CcSEcCtD
Gemcitabine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000239	0.000622	CcSEcCtD
Gemcitabine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000238	0.00062	CcSEcCtD
Gemcitabine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000238	0.00062	CcSEcCtD
Gemcitabine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000238	0.000619	CcSEcCtD
Gemcitabine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000237	0.000618	CcSEcCtD
Gemcitabine—Hypertension—Metformin—type 2 diabetes mellitus	0.000236	0.000615	CcSEcCtD
Gemcitabine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000236	0.000614	CcSEcCtD
Gemcitabine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000235	0.000613	CcSEcCtD
Gemcitabine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000235	0.000613	CcSEcCtD
Gemcitabine—Back pain—Losartan—type 2 diabetes mellitus	0.000235	0.000612	CcSEcCtD
Gemcitabine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000234	0.00061	CcSEcCtD
Gemcitabine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000234	0.000609	CcSEcCtD
Gemcitabine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000233	0.000608	CcSEcCtD
Gemcitabine—Chest pain—Metformin—type 2 diabetes mellitus	0.000233	0.000607	CcSEcCtD
Gemcitabine—Myalgia—Metformin—type 2 diabetes mellitus	0.000233	0.000607	CcSEcCtD
Gemcitabine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000233	0.000606	CcSEcCtD
Gemcitabine—ABCB1—liver—type 2 diabetes mellitus	0.000232	0.00166	CbGeAlD
Gemcitabine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000232	0.000604	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000231	0.000602	CcSEcCtD
Gemcitabine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000231	0.000602	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00023	0.0006	CcSEcCtD
Gemcitabine—Discomfort—Metformin—type 2 diabetes mellitus	0.00023	0.000599	CcSEcCtD
Gemcitabine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00023	0.000599	CcSEcCtD
Gemcitabine—Nausea—Glipizide—type 2 diabetes mellitus	0.000229	0.000597	CcSEcCtD
Gemcitabine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000229	0.000597	CcSEcCtD
Gemcitabine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000229	0.000597	CcSEcCtD
Gemcitabine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000228	0.000595	CcSEcCtD
Gemcitabine—Pain—Gliclazide—type 2 diabetes mellitus	0.000228	0.000594	CcSEcCtD
Gemcitabine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000228	0.000594	CcSEcCtD
Gemcitabine—Rash—Glimepiride—type 2 diabetes mellitus	0.000227	0.000592	CcSEcCtD
Gemcitabine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000227	0.000591	CcSEcCtD
Gemcitabine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00059	CcSEcCtD
Gemcitabine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000226	0.000589	CcSEcCtD
Gemcitabine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000226	0.000589	CcSEcCtD
Gemcitabine—Headache—Glimepiride—type 2 diabetes mellitus	0.000226	0.000588	CcSEcCtD
Gemcitabine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000225	0.000587	CcSEcCtD
Gemcitabine—Cough—Irbesartan—type 2 diabetes mellitus	0.000225	0.000587	CcSEcCtD
Gemcitabine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000225	0.000586	CcSEcCtD
Gemcitabine—Anaemia—Losartan—type 2 diabetes mellitus	0.000225	0.000585	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000223	0.000582	CcSEcCtD
Gemcitabine—Oedema—Metformin—type 2 diabetes mellitus	0.000223	0.000582	CcSEcCtD
Gemcitabine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000223	0.000581	CcSEcCtD
Gemcitabine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000222	0.000579	CcSEcCtD
Gemcitabine—Infection—Metformin—type 2 diabetes mellitus	0.000222	0.000578	CcSEcCtD
Gemcitabine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000222	0.000578	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000221	0.000575	CcSEcCtD
Gemcitabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00022	0.000573	CcSEcCtD
Gemcitabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00022	0.000573	CcSEcCtD
Gemcitabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00022	0.000572	CcSEcCtD
Gemcitabine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00022	0.000572	CcSEcCtD
Gemcitabine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00022	0.000572	CcSEcCtD
Gemcitabine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000219	0.000571	CcSEcCtD
Gemcitabine—Malaise—Losartan—type 2 diabetes mellitus	0.000219	0.000571	CcSEcCtD
Gemcitabine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000219	0.00057	CcSEcCtD
Gemcitabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000219	0.000569	CcSEcCtD
Gemcitabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000219	0.000569	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000218	0.000569	CcSEcCtD
Gemcitabine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000218	0.000568	CcSEcCtD
Gemcitabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000218	0.000567	CcSEcCtD
Gemcitabine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000217	0.000566	CcSEcCtD
Gemcitabine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000217	0.000566	CcSEcCtD
Gemcitabine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000217	0.000565	CcSEcCtD
Gemcitabine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000216	0.000563	CcSEcCtD
Gemcitabine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000216	0.000562	CcSEcCtD
Gemcitabine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000216	0.000562	CcSEcCtD
Gemcitabine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000214	0.000558	CcSEcCtD
Gemcitabine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000214	0.000557	CcSEcCtD
Gemcitabine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000213	0.000556	CcSEcCtD
Gemcitabine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000213	0.000555	CcSEcCtD
Gemcitabine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000213	0.000555	CcSEcCtD
Gemcitabine—Anorexia—Metformin—type 2 diabetes mellitus	0.000213	0.000554	CcSEcCtD
Gemcitabine—Cough—Losartan—type 2 diabetes mellitus	0.000212	0.000552	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000212	0.000551	CcSEcCtD
Gemcitabine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000211	0.000551	CcSEcCtD
Gemcitabine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000211	0.000551	CcSEcCtD
Gemcitabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000211	0.000549	CcSEcCtD
Gemcitabine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000211	0.000549	CcSEcCtD
Gemcitabine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000211	0.000549	CcSEcCtD
Gemcitabine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000211	0.000549	CcSEcCtD
Gemcitabine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00021	0.000548	CcSEcCtD
Gemcitabine—Constipation—Valsartan—type 2 diabetes mellitus	0.00021	0.000546	CcSEcCtD
Gemcitabine—Infection—Irbesartan—type 2 diabetes mellitus	0.000209	0.000545	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000209	0.000545	CcSEcCtD
Gemcitabine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000209	0.000544	CcSEcCtD
Gemcitabine—Hypotension—Metformin—type 2 diabetes mellitus	0.000209	0.000543	CcSEcCtD
Gemcitabine—Erythema—Ramipril—type 2 diabetes mellitus	0.000208	0.000543	CcSEcCtD
Gemcitabine—Pain—Orlistat—type 2 diabetes mellitus	0.000207	0.00054	CcSEcCtD
Gemcitabine—Chest pain—Losartan—type 2 diabetes mellitus	0.000207	0.000539	CcSEcCtD
Gemcitabine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000207	0.000539	CcSEcCtD
Gemcitabine—Myalgia—Losartan—type 2 diabetes mellitus	0.000207	0.000539	CcSEcCtD
Gemcitabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000207	0.000538	CcSEcCtD
Gemcitabine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000207	0.000538	CcSEcCtD
Gemcitabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000206	0.000537	CcSEcCtD
Gemcitabine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000205	0.000534	CcSEcCtD
Gemcitabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000205	0.000533	CcSEcCtD
Gemcitabine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000205	0.000533	CcSEcCtD
Gemcitabine—Discomfort—Losartan—type 2 diabetes mellitus	0.000204	0.000532	CcSEcCtD
Gemcitabine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000204	0.000531	CcSEcCtD
Gemcitabine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00053	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000203	0.00053	CcSEcCtD
Gemcitabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000203	0.00053	CcSEcCtD
Gemcitabine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000201	0.000523	CcSEcCtD
Gemcitabine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.0002	0.000522	CcSEcCtD
Gemcitabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.0002	0.00052	CcSEcCtD
Gemcitabine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000199	0.000518	CcSEcCtD
Gemcitabine—Somnolence—Metformin—type 2 diabetes mellitus	0.000199	0.000517	CcSEcCtD
Gemcitabine—Oedema—Losartan—type 2 diabetes mellitus	0.000198	0.000516	CcSEcCtD
Gemcitabine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000198	0.000516	CcSEcCtD
Gemcitabine—Infection—Losartan—type 2 diabetes mellitus	0.000197	0.000513	CcSEcCtD
Gemcitabine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000197	0.000513	CcSEcCtD
Gemcitabine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000194	0.000506	CcSEcCtD
Gemcitabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000194	0.000506	CcSEcCtD
Gemcitabine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000194	0.000506	CcSEcCtD
Gemcitabine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000193	0.000503	CcSEcCtD
Gemcitabine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000193	0.000503	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000193	0.000502	CcSEcCtD
Gemcitabine—Fatigue—Metformin—type 2 diabetes mellitus	0.000193	0.000501	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000192	0.0005	CcSEcCtD
Gemcitabine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000192	0.000499	CcSEcCtD
Gemcitabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000192	0.000499	CcSEcCtD
Gemcitabine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000191	0.000499	CcSEcCtD
Gemcitabine—Constipation—Metformin—type 2 diabetes mellitus	0.000191	0.000497	CcSEcCtD
Gemcitabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000189	0.000493	CcSEcCtD
Gemcitabine—Anorexia—Losartan—type 2 diabetes mellitus	0.000189	0.000492	CcSEcCtD
Gemcitabine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000189	0.000492	CcSEcCtD
Gemcitabine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000189	0.000492	CcSEcCtD
Gemcitabine—Malaise—Ramipril—type 2 diabetes mellitus	0.000188	0.000489	CcSEcCtD
Gemcitabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000188	0.000489	CcSEcCtD
Gemcitabine—Rash—Glyburide—type 2 diabetes mellitus	0.000187	0.000488	CcSEcCtD
Gemcitabine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000187	0.000488	CcSEcCtD
Gemcitabine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000187	0.000488	CcSEcCtD
Gemcitabine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000186	0.000486	CcSEcCtD
Gemcitabine—Headache—Glyburide—type 2 diabetes mellitus	0.000186	0.000485	CcSEcCtD
Gemcitabine—Hypotension—Losartan—type 2 diabetes mellitus	0.000185	0.000483	CcSEcCtD
Gemcitabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000184	0.000479	CcSEcCtD
Gemcitabine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000183	0.000477	CcSEcCtD
Gemcitabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000183	0.000476	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000182	0.000474	CcSEcCtD
Gemcitabine—Cough—Ramipril—type 2 diabetes mellitus	0.000182	0.000474	CcSEcCtD
Gemcitabine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000182	0.000473	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000181	0.000471	CcSEcCtD
Gemcitabine—Pain—Irbesartan—type 2 diabetes mellitus	0.00018	0.000469	CcSEcCtD
Gemcitabine—Constipation—Irbesartan—type 2 diabetes mellitus	0.00018	0.000469	CcSEcCtD
Gemcitabine—Insomnia—Losartan—type 2 diabetes mellitus	0.000179	0.000467	CcSEcCtD
Gemcitabine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000178	0.000464	CcSEcCtD
Gemcitabine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000177	0.000462	CcSEcCtD
Gemcitabine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000177	0.000462	CcSEcCtD
Gemcitabine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000177	0.000462	CcSEcCtD
Gemcitabine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000177	0.00046	CcSEcCtD
Gemcitabine—Nausea—Glyburide—type 2 diabetes mellitus	0.000177	0.00046	CcSEcCtD
Gemcitabine—Somnolence—Losartan—type 2 diabetes mellitus	0.000176	0.000459	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000176	0.000459	CcSEcCtD
Gemcitabine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000176	0.000458	CcSEcCtD
Gemcitabine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000175	0.000456	CcSEcCtD
Gemcitabine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000174	0.000453	CcSEcCtD
Gemcitabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000174	0.000452	CcSEcCtD
Gemcitabine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000173	0.000452	CcSEcCtD
Gemcitabine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000172	0.000449	CcSEcCtD
Gemcitabine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000171	0.000446	CcSEcCtD
Gemcitabine—Fatigue—Losartan—type 2 diabetes mellitus	0.000171	0.000445	CcSEcCtD
Gemcitabine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00017	0.000443	CcSEcCtD
Gemcitabine—Oedema—Ramipril—type 2 diabetes mellitus	0.00017	0.000443	CcSEcCtD
Gemcitabine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00017	0.000442	CcSEcCtD
Gemcitabine—Pain—Losartan—type 2 diabetes mellitus	0.00017	0.000442	CcSEcCtD
Gemcitabine—Constipation—Losartan—type 2 diabetes mellitus	0.00017	0.000442	CcSEcCtD
Gemcitabine—Rash—Gliclazide—type 2 diabetes mellitus	0.000168	0.000438	CcSEcCtD
Gemcitabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000168	0.000438	CcSEcCtD
Gemcitabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000168	0.000437	CcSEcCtD
Gemcitabine—Headache—Gliclazide—type 2 diabetes mellitus	0.000167	0.000435	CcSEcCtD
Gemcitabine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000167	0.000434	CcSEcCtD
Gemcitabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000167	0.000434	CcSEcCtD
Gemcitabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000166	0.000434	CcSEcCtD
Gemcitabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000166	0.000432	CcSEcCtD
Gemcitabine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000165	0.00043	CcSEcCtD
Gemcitabine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000164	0.000428	CcSEcCtD
Gemcitabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000163	0.000426	CcSEcCtD
Gemcitabine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000162	0.000422	CcSEcCtD
Gemcitabine—Asthenia—Metformin—type 2 diabetes mellitus	0.00016	0.000417	CcSEcCtD
Gemcitabine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000159	0.000414	CcSEcCtD
Gemcitabine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000159	0.000413	CcSEcCtD
Gemcitabine—Pruritus—Metformin—type 2 diabetes mellitus	0.000158	0.000411	CcSEcCtD
Gemcitabine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000157	0.000408	CcSEcCtD
Gemcitabine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000156	0.000406	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000155	0.000403	CcSEcCtD
Gemcitabine—Rash—Valsartan—type 2 diabetes mellitus	0.000155	0.000403	CcSEcCtD
Gemcitabine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000154	0.000402	CcSEcCtD
Gemcitabine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000154	0.000401	CcSEcCtD
Gemcitabine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000154	0.000401	CcSEcCtD
Gemcitabine—Headache—Valsartan—type 2 diabetes mellitus	0.000154	0.0004	CcSEcCtD
Gemcitabine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000153	0.000398	CcSEcCtD
Gemcitabine—Rash—Orlistat—type 2 diabetes mellitus	0.000153	0.000398	CcSEcCtD
Gemcitabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000153	0.000398	CcSEcCtD
Gemcitabine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000153	0.000397	CcSEcCtD
Gemcitabine—Headache—Orlistat—type 2 diabetes mellitus	0.000152	0.000395	CcSEcCtD
Gemcitabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000152	0.000395	CcSEcCtD
Gemcitabine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000151	0.000394	CcSEcCtD
Gemcitabine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000151	0.000394	CcSEcCtD
Gemcitabine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000149	0.000388	CcSEcCtD
Gemcitabine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000148	0.000385	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000147	0.000382	CcSEcCtD
Gemcitabine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000147	0.000382	CcSEcCtD
Gemcitabine—Nausea—Valsartan—type 2 diabetes mellitus	0.000146	0.000379	CcSEcCtD
Gemcitabine—Constipation—Ramipril—type 2 diabetes mellitus	0.000145	0.000379	CcSEcCtD
Gemcitabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000144	0.000375	CcSEcCtD
Gemcitabine—Nausea—Orlistat—type 2 diabetes mellitus	0.000144	0.000375	CcSEcCtD
Gemcitabine—Asthenia—Losartan—type 2 diabetes mellitus	0.000142	0.000371	CcSEcCtD
Gemcitabine—Vomiting—Metformin—type 2 diabetes mellitus	0.000142	0.00037	CcSEcCtD
Gemcitabine—Rash—Metformin—type 2 diabetes mellitus	0.000141	0.000367	CcSEcCtD
Gemcitabine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000141	0.000366	CcSEcCtD
Gemcitabine—Pruritus—Losartan—type 2 diabetes mellitus	0.00014	0.000365	CcSEcCtD
Gemcitabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00014	0.000365	CcSEcCtD
Gemcitabine—Headache—Metformin—type 2 diabetes mellitus	0.00014	0.000364	CcSEcCtD
Gemcitabine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000136	0.000353	CcSEcCtD
Gemcitabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000134	0.00035	CcSEcCtD
Gemcitabine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000134	0.000349	CcSEcCtD
Gemcitabine—Rash—Irbesartan—type 2 diabetes mellitus	0.000133	0.000346	CcSEcCtD
Gemcitabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000133	0.000346	CcSEcCtD
Gemcitabine—Nausea—Metformin—type 2 diabetes mellitus	0.000133	0.000345	CcSEcCtD
Gemcitabine—Headache—Irbesartan—type 2 diabetes mellitus	0.000132	0.000344	CcSEcCtD
Gemcitabine—Vomiting—Losartan—type 2 diabetes mellitus	0.000126	0.000328	CcSEcCtD
Gemcitabine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000125	0.000326	CcSEcCtD
Gemcitabine—Rash—Losartan—type 2 diabetes mellitus	0.000125	0.000326	CcSEcCtD
Gemcitabine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000125	0.000325	CcSEcCtD
Gemcitabine—Headache—Losartan—type 2 diabetes mellitus	0.000124	0.000324	CcSEcCtD
Gemcitabine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000122	0.000318	CcSEcCtD
Gemcitabine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00012	0.000313	CcSEcCtD
Gemcitabine—Nausea—Losartan—type 2 diabetes mellitus	0.000118	0.000307	CcSEcCtD
Gemcitabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000116	0.000303	CcSEcCtD
Gemcitabine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000108	0.000282	CcSEcCtD
Gemcitabine—Rash—Ramipril—type 2 diabetes mellitus	0.000107	0.000279	CcSEcCtD
Gemcitabine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000107	0.000279	CcSEcCtD
Gemcitabine—Headache—Ramipril—type 2 diabetes mellitus	0.000107	0.000277	CcSEcCtD
Gemcitabine—Nausea—Ramipril—type 2 diabetes mellitus	0.000101	0.000263	CcSEcCtD
Gemcitabine—TYMS—Metabolism—GCK—type 2 diabetes mellitus	3.48e-05	0.000149	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARA—type 2 diabetes mellitus	3.48e-05	0.000149	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAT—type 2 diabetes mellitus	3.48e-05	0.000149	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP11A1—type 2 diabetes mellitus	3.46e-05	0.000148	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	3.45e-05	0.000148	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.44e-05	0.000147	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—type 2 diabetes mellitus	3.43e-05	0.000147	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—type 2 diabetes mellitus	3.41e-05	0.000146	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC9A1—type 2 diabetes mellitus	3.4e-05	0.000145	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	3.4e-05	0.000145	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOB—type 2 diabetes mellitus	3.4e-05	0.000145	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOB—type 2 diabetes mellitus	3.37e-05	0.000144	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AGT—type 2 diabetes mellitus	3.37e-05	0.000144	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CETP—type 2 diabetes mellitus	3.36e-05	0.000144	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNB3—type 2 diabetes mellitus	3.33e-05	0.000142	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.33e-05	0.000142	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HMOX1—type 2 diabetes mellitus	3.31e-05	0.000142	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CALM1—type 2 diabetes mellitus	3.31e-05	0.000142	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—type 2 diabetes mellitus	3.3e-05	0.000141	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOE—type 2 diabetes mellitus	3.3e-05	0.000141	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.3e-05	0.000141	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—type 2 diabetes mellitus	3.28e-05	0.000141	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAT—type 2 diabetes mellitus	3.27e-05	0.00014	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOA1—type 2 diabetes mellitus	3.26e-05	0.00014	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3R1—type 2 diabetes mellitus	3.26e-05	0.00014	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NOS3—type 2 diabetes mellitus	3.26e-05	0.00014	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—LPL—type 2 diabetes mellitus	3.24e-05	0.000139	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	3.23e-05	0.000138	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—LPL—type 2 diabetes mellitus	3.22e-05	0.000138	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	3.22e-05	0.000138	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	3.19e-05	0.000137	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ADCY5—type 2 diabetes mellitus	3.17e-05	0.000136	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOB—type 2 diabetes mellitus	3.17e-05	0.000136	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—type 2 diabetes mellitus	3.17e-05	0.000136	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPX1—type 2 diabetes mellitus	3.16e-05	0.000135	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ADCY5—type 2 diabetes mellitus	3.15e-05	0.000135	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GPX1—type 2 diabetes mellitus	3.14e-05	0.000135	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSMD6—type 2 diabetes mellitus	3.12e-05	0.000134	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SREBF1—type 2 diabetes mellitus	3.12e-05	0.000134	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SNAP25—type 2 diabetes mellitus	3.12e-05	0.000134	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—type 2 diabetes mellitus	3.09e-05	0.000132	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CD36—type 2 diabetes mellitus	3.08e-05	0.000132	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CTGF—type 2 diabetes mellitus	3.07e-05	0.000131	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CD36—type 2 diabetes mellitus	3.06e-05	0.000131	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.04e-05	0.00013	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMGCR—type 2 diabetes mellitus	3.04e-05	0.00013	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—type 2 diabetes mellitus	3.04e-05	0.00013	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—LPL—type 2 diabetes mellitus	3.03e-05	0.00013	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.02e-05	0.000129	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.99e-05	0.000128	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—type 2 diabetes mellitus	2.98e-05	0.000128	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	2.98e-05	0.000127	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADRA2A—type 2 diabetes mellitus	2.97e-05	0.000127	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	2.97e-05	0.000127	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ADCY5—type 2 diabetes mellitus	2.97e-05	0.000127	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GPX1—type 2 diabetes mellitus	2.96e-05	0.000127	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—type 2 diabetes mellitus	2.92e-05	0.000125	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—type 2 diabetes mellitus	2.9e-05	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.89e-05	0.000124	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CD36—type 2 diabetes mellitus	2.88e-05	0.000123	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—type 2 diabetes mellitus	2.87e-05	0.000123	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARA—type 2 diabetes mellitus	2.86e-05	0.000123	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2E1—type 2 diabetes mellitus	2.86e-05	0.000122	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARA—type 2 diabetes mellitus	2.85e-05	0.000122	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPP2CA—type 2 diabetes mellitus	2.84e-05	0.000122	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC2A1—type 2 diabetes mellitus	2.82e-05	0.000121	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A2—type 2 diabetes mellitus	2.82e-05	0.000121	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—INS—type 2 diabetes mellitus	2.82e-05	0.000121	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AGT—type 2 diabetes mellitus	2.77e-05	0.000119	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	2.77e-05	0.000119	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.77e-05	0.000118	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AGT—type 2 diabetes mellitus	2.76e-05	0.000118	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP3A4—type 2 diabetes mellitus	2.75e-05	0.000118	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—type 2 diabetes mellitus	2.73e-05	0.000117	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CALM1—type 2 diabetes mellitus	2.73e-05	0.000117	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOE—type 2 diabetes mellitus	2.72e-05	0.000116	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CALM1—type 2 diabetes mellitus	2.71e-05	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GCG—type 2 diabetes mellitus	2.71e-05	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC2A4—type 2 diabetes mellitus	2.71e-05	0.000116	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOE—type 2 diabetes mellitus	2.7e-05	0.000116	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOA1—type 2 diabetes mellitus	2.69e-05	0.000115	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARA—type 2 diabetes mellitus	2.68e-05	0.000115	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOA1—type 2 diabetes mellitus	2.67e-05	0.000114	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	2.6e-05	0.000111	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	2.6e-05	0.000111	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AGT—type 2 diabetes mellitus	2.59e-05	0.000111	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—type 2 diabetes mellitus	2.58e-05	0.000111	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CALM1—type 2 diabetes mellitus	2.55e-05	0.000109	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—type 2 diabetes mellitus	2.54e-05	0.000109	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOA1—type 2 diabetes mellitus	2.51e-05	0.000107	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	2.48e-05	0.000106	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.47e-05	0.000106	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—type 2 diabetes mellitus	2.47e-05	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	2.47e-05	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	2.47e-05	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	2.44e-05	0.000105	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—type 2 diabetes mellitus	2.43e-05	0.000104	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.4e-05	0.000103	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	2.38e-05	0.000102	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—type 2 diabetes mellitus	2.37e-05	0.000101	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.35e-05	0.000101	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—type 2 diabetes mellitus	2.35e-05	0.000101	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.33e-05	9.99e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNB3—type 2 diabetes mellitus	2.33e-05	9.99e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMOX1—type 2 diabetes mellitus	2.32e-05	9.94e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—INS—type 2 diabetes mellitus	2.32e-05	9.94e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—INS—type 2 diabetes mellitus	2.31e-05	9.88e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.29e-05	9.82e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.29e-05	9.82e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAT—type 2 diabetes mellitus	2.29e-05	9.81e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—type 2 diabetes mellitus	2.26e-05	9.68e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	2.24e-05	9.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	2.23e-05	9.53e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOB—type 2 diabetes mellitus	2.22e-05	9.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	2.21e-05	9.47e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—type 2 diabetes mellitus	2.21e-05	9.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	2.17e-05	9.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	2.17e-05	9.3e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—INS—type 2 diabetes mellitus	2.17e-05	9.29e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—type 2 diabetes mellitus	2.16e-05	9.27e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	2.13e-05	9.12e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—type 2 diabetes mellitus	2.13e-05	9.11e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—LPL—type 2 diabetes mellitus	2.12e-05	9.09e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—type 2 diabetes mellitus	2.12e-05	9.06e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	2.1e-05	8.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	2.1e-05	8.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	2.1e-05	8.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.1e-05	8.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	2.1e-05	8.98e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ADCY5—type 2 diabetes mellitus	2.08e-05	8.9e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GPX1—type 2 diabetes mellitus	2.07e-05	8.87e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.04e-05	8.72e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—type 2 diabetes mellitus	2.04e-05	8.72e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	2.03e-05	8.7e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	2.02e-05	8.67e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—type 2 diabetes mellitus	2.02e-05	8.66e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.02e-05	8.66e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CD36—type 2 diabetes mellitus	2.02e-05	8.64e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPP2CA—type 2 diabetes mellitus	1.99e-05	8.53e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—type 2 diabetes mellitus	1.99e-05	8.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.95e-05	8.35e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.92e-05	8.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.92e-05	8.22e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—type 2 diabetes mellitus	1.91e-05	8.19e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3R1—type 2 diabetes mellitus	1.9e-05	8.14e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—type 2 diabetes mellitus	1.9e-05	8.14e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.88e-05	8.04e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARA—type 2 diabetes mellitus	1.88e-05	8.03e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.87e-05	8.01e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—type 2 diabetes mellitus	1.86e-05	7.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.86e-05	7.96e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—type 2 diabetes mellitus	1.85e-05	7.92e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AGT—type 2 diabetes mellitus	1.82e-05	7.78e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CALM1—type 2 diabetes mellitus	1.79e-05	7.65e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.78e-05	7.64e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.78e-05	7.64e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.78e-05	7.64e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.78e-05	7.64e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOE—type 2 diabetes mellitus	1.78e-05	7.62e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOA1—type 2 diabetes mellitus	1.76e-05	7.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.76e-05	7.52e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—type 2 diabetes mellitus	1.74e-05	7.45e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.71e-05	7.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.71e-05	7.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.65e-05	7.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.65e-05	7.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.64e-05	7.01e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.62e-05	6.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.59e-05	6.83e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.59e-05	6.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.59e-05	6.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.59e-05	6.81e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—type 2 diabetes mellitus	1.55e-05	6.64e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.54e-05	6.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.53e-05	6.55e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—INS—type 2 diabetes mellitus	1.52e-05	6.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.52e-05	6.49e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—type 2 diabetes mellitus	1.5e-05	6.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.5e-05	6.4e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.47e-05	6.27e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.46e-05	6.27e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.44e-05	6.14e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.4e-05	5.99e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—type 2 diabetes mellitus	1.39e-05	5.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.37e-05	5.87e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.37e-05	5.85e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.35e-05	5.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.35e-05	5.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.35e-05	5.79e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.35e-05	5.79e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3R1—type 2 diabetes mellitus	1.33e-05	5.71e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—type 2 diabetes mellitus	1.33e-05	5.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.3e-05	5.55e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.24e-05	5.29e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—type 2 diabetes mellitus	1.22e-05	5.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.21e-05	5.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.16e-05	4.96e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-05	4.87e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	1.13e-05	4.82e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.1e-05	4.72e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.1e-05	4.72e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.08e-05	4.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.07e-05	4.6e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.07e-05	4.6e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.07e-05	4.6e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.07e-05	4.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.05e-05	4.49e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.04e-05	4.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.02e-05	4.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	9.63e-06	4.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	9.63e-06	4.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	9.63e-06	4.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	9.46e-06	4.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	9.37e-06	4.01e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—type 2 diabetes mellitus	9.36e-06	4.01e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—type 2 diabetes mellitus	9.3e-06	3.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.19e-06	3.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.17e-06	3.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.81e-06	3.77e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—type 2 diabetes mellitus	8.75e-06	3.74e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.71e-06	3.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.71e-06	3.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.5e-06	3.64e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	8.35e-06	3.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.35e-06	3.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	7.2e-06	3.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.2e-06	3.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	7.17e-06	3.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	7.07e-06	3.03e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.87e-06	2.94e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	6.68e-06	2.86e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	6.56e-06	2.81e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	6.42e-06	2.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	6.4e-06	2.74e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	6.23e-06	2.67e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.15e-06	2.63e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—type 2 diabetes mellitus	6.13e-06	2.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.9e-06	2.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.79e-06	2.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.61e-06	2.4e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	5.51e-06	2.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	5.49e-06	2.35e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	5.43e-06	2.33e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.79e-06	2.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.69e-06	2.01e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.3e-06	1.84e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.12e-06	1.76e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.12e-06	1.76e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.77e-06	1.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.89e-06	8.1e-06	CbGpPWpGaD
